PersonFounderExecutive
Julia Owens
Julia C. Owens is a biopharmaceutical executive who in October 2025 became CEO of Basking Biosciences, a clinical-stage company building the first reversible thrombolytic therapy for acute ischemic stroke. With a UCSF Ph.D. and more than 25 years in the industry, she co-founded and ran Millendo Therapeutics for nearly a decade through its NASDAQ debut, later led Ananke Therapeutics, advises GV (Google Ventures) on women's health, chairs Sena Therapeutics, and co-founded the Biotech CEO Sisterhood to put more women in the corner office.
julia owensjulia c. owensbasking biosciencesbiotech ceomillendo therapeuticsrna aptamer